14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group (Q33347787)
Jump to navigation
Jump to search
scientific article published on May 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group |
scientific article published on May 1, 2003 |
Statements
1 reference
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group (English)
1 reference
14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group (English)
1 reference
1 reference
J. Franklin
German Hodgkin's Lymphoma Study Group
1 reference
M. Sieber
H. Bredenfeld
A. Josting
T. Reineke
U. Rueffer
T. Koch
R. Naumann
F. Boissevain
P. Koch
P. Worst
M. Soekler
H. Eich
H. K. Müller-Hermelink
U. Paulus
J. Wolf
A. Engert
1 May 2003
1 reference
1 reference
21
1 reference
1734-1739
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference